Literature DB >> 10028309

Management of a premature infant with moderate haemophilia A using recombinant factor VIII.

R F Gale1, M F Hird, B T Colvin.   

Abstract

The birth of a very premature infant with haemophilia A is a rare event. In this case report the problems posed in the management of a child with a factor VIII level of 0.03 IU mL-1 born at 28 weeks of gestation and weighing 1590 g are considered. The value of recombinant factor VIII, the pharmacokinetics of factor VIII in this situation and the importance of close cooperation between paediatricians and haematologists are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10028309     DOI: 10.1046/j.1365-2516.1998.00201.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

1.  A survey of the management of newborns with severe hemophilia in Canada.

Authors:  Paul C Moorehead; Jamie Ray; Nicholas J Barrowman; Brigitte Lemyre; Robert Klaassen
Journal:  Paediatr Child Health       Date:  2013-04       Impact factor: 2.253

2.  Haemophilia A in two premature infants.

Authors:  Christoph Bidlingmaier; Frauke Bergmann; Karin Kurnik
Journal:  Eur J Pediatr       Date:  2004-12-03       Impact factor: 3.183

Review 3.  Pediatric Dosing and Body Size in Biotherapeutics.

Authors:  Rong Shi; Hartmut Derendorf
Journal:  Pharmaceutics       Date:  2010-12-16       Impact factor: 6.321

4.  Severe haemophilia A in a preterm girl with Turner syndrome: case report - a diagnostic and therapeutic challenge for a paediatrician (Part 2).

Authors:  Berendt Agnieszka; Wójtowicz-Marzec Monika; Wysokińska Barbara; Kwaśniewska Anna
Journal:  Ital J Pediatr       Date:  2021-07-13       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.